FDA Approved: LESCOL XL — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for LESCOL XL (fluvastatin sodium) filed by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Heterozygous Familial Hypercholesterolemia
• Hypercholesterolemia
• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• LESCOL XL (Fluvastatin sodium)

Snippet

SUPPL AP for LESCOL XL (FLUVASTATIN SODIUM)